Imbue

About
What does Imbue do?
Imbue builds products that empower humans in the AI age by giving them control over their digital world, from modifying algorithms to building personal software. Their core product, Sculptor, is a UI for coding agents designed to make AI coding reliable, collaborative, and accessible. Imbue aims to make software creation accessible to all, enabling individuals to shape their computational future.
What is Imbue's revenue?
StartupHub estimates Imbue's annual revenue at $19.6M (range $11.1M to $55.3M, 63% confidence), based on comparable companies in the sector.
Where is Imbue headquartered?
Imbue is headquartered in San Francisco, United States.
When was Imbue founded?
Imbue was founded in 2020.
What industry does Imbue operate in?
Imbue operates in Artificial Intelligence, Foundation Models, Reasoning AI, NeoLab, Frontier AI Lab, AGI Research.
How many employees does Imbue have?
Imbue has approximately 77 people on record.
An independent artificial-consciousness research initiative with visible sources, method, provenance and limitations.
Automating scientific and engineering discovery through AI systems that propose, run, and learn from experiments.
Something to bend your brain is loading. mindboggling.ai — coming soon.
A lean product studio building and acquiring focused digital tools for the AI-native era.
XITU - Pioneering embodied AI and humanoid robotics for a smarter world.
Leiolai is an intelligence built by Entlegnant that runs on consumer hardware and pays users for saving water.
Procambrian is an AI company developing advanced AI models for complex problem-solving and scientific discovery.
A mysterious startup with a cryptic premise about something awakening in the Pacific.
An entrant is a company tagged Frontier AI Lab whose domain was first registered in the window, counted from registry records in the StartupHub directory. 2 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.
